Gayle K Deutsch1, Katharine A Hagerman1, Jacinda Sampson1, Gersham Dent2, Jeanne Dekdebrun3, Dana M Parker1, Charles A Thornton3, Chad R Heatwole3, Sub H Subramony4, Ami K Mankodi5, Tetsuo Ashizawa6, Jeffrey M Statland7, W David Arnold8, Richard T Moxley3, John W Day1. 1. Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA. 2. Biogen, Cambridge, MA. 3. Department of Neurology, The University of Rochester Medical Center, Rochester, NY. 4. Department of Neurology, Norman Fixel Center for Neurological Disorders, University of Florida College of Medicine, Gainesville, FL. 5. National Institute of Neurological Disorders and Stroke, Rockville, MD. 6. Department of Neurology, Weill Cornell Medicine at Houston Methodist Hospital, Houston, TX. 7. Department of Neurology, University of Kansas Medical Center, Kansas City, KS. 8. Departments of Neurology, PM&R, Neuroscience and Physiology and Cell Biology, The Ohio State University, Columbus, OH.
Abstract
INTRODUCTION/AIMS: Myotonic dystrophy type 1 (DM1) is known to affect cognitive function, but the best methods to assess central nervous system involvement in multicenter studies have not been determined. In this study our primary aim was to evaluate the potential of computerized cognitive tests to assess cognition in DM1. METHODS: We conducted a prospective, longitudinal, observational study of 113 adults with DM1 at six sites. Psychomotor speed, attention, working memory, and executive functioning were assessed at baseline, 3 months, and 12 months using computerized cognitive tests. Results were compared with assessments of muscle function and patient reported outcomes (PROs), including the Myotonic Dystrophy Health Index (MDHI) and the 5-dimension EuroQol (EQ-5D-5L) questionnaire. RESULTS: Based on intraclass correlation coefficients, computerized cognitive tests had moderate to good reliability for psychomotor speed (0.76), attention (0.82), working memory speed (0.79), working memory accuracy (0.65), and executive functioning (0.87). Performance at baseline was lowest for working memory accuracy (P < .0001). Executive function performance improved from baseline to 3 months (P < .0001), without further changes over 1 year. There was a moderate correlation between poorer executive function and larger CTG repeat size (r = -0.433). There were some weak associations between PROs and cognitive performance. DISCUSSION: Computerized tests of cognition are feasible in multicenter studies of DM1. Poor performance was exhibited in working memory, which may be a useful variable in clinical trials. Learning effects may have contributed to the improvement in executive functioning. The relationship between PROs and cognitive impairment in DM1 requires further study.
INTRODUCTION/AIMS: Myotonic dystrophy type 1 (DM1) is known to affect cognitive function, but the best methods to assess central nervous system involvement in multicenter studies have not been determined. In this study our primary aim was to evaluate the potential of computerized cognitive tests to assess cognition in DM1. METHODS: We conducted a prospective, longitudinal, observational study of 113 adults with DM1 at six sites. Psychomotor speed, attention, working memory, and executive functioning were assessed at baseline, 3 months, and 12 months using computerized cognitive tests. Results were compared with assessments of muscle function and patient reported outcomes (PROs), including the Myotonic Dystrophy Health Index (MDHI) and the 5-dimension EuroQol (EQ-5D-5L) questionnaire. RESULTS: Based on intraclass correlation coefficients, computerized cognitive tests had moderate to good reliability for psychomotor speed (0.76), attention (0.82), working memory speed (0.79), working memory accuracy (0.65), and executive functioning (0.87). Performance at baseline was lowest for working memory accuracy (P < .0001). Executive function performance improved from baseline to 3 months (P < .0001), without further changes over 1 year. There was a moderate correlation between poorer executive function and larger CTG repeat size (r = -0.433). There were some weak associations between PROs and cognitive performance. DISCUSSION: Computerized tests of cognition are feasible in multicenter studies of DM1. Poor performance was exhibited in working memory, which may be a useful variable in clinical trials. Learning effects may have contributed to the improvement in executive functioning. The relationship between PROs and cognitive impairment in DM1 requires further study.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Yen Ying Lim; Judith Jaeger; Karra Harrington; Tim Ashwood; Kathryn A Ellis; Albrecht Stöffler; Cassandra Szoeke; Rebecca Lachovitzki; Ralph N Martins; Victor L Villemagne; Ashley Bush; Colin L Masters; Christopher C Rowe; David Ames; David Darby; Paul Maruff Journal: Arch Clin Neuropsychol Date: 2013-04-03 Impact factor: 2.813
Authors: Kees Okkersen; Melanie Buskes; Johannes Groenewoud; Roy P C Kessels; Hans Knoop; Baziel van Engelen; Joost Raaphorst Journal: Cortex Date: 2017-08-16 Impact factor: 4.027
Authors: Masayuki Nakamori; Krzysztof Sobczak; Araya Puwanant; Steve Welle; Katy Eichinger; Shree Pandya; Jeannne Dekdebrun; Chad R Heatwole; Michael P McDermott; Tian Chen; Melissa Cline; Rabi Tawil; Robert J Osborne; Thurman M Wheeler; Maurice S Swanson; Richard T Moxley; Charles A Thornton Journal: Ann Neurol Date: 2013-12 Impact factor: 10.422